135 related articles for article (PubMed ID: 30055888)
1. Cyclic analogue of S-benzylisothiourea that suppresses kynurenine production without inhibiting indoleamine 2,3-dioxygenase activity.
Fukuda M; Sasaki T; Hashimoto T; Miyachi H; Waki M; Asai A; Takikawa O; Ohno O; Matsuno K
Bioorg Med Chem Lett; 2018 Sep; 28(17):2846-2849. PubMed ID: 30055888
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel kynurenine production-inhibiting benzenesulfonamide derivatives in cancer cells.
Nakano S; Takai K; Isaka Y; Takahashi S; Unno Y; Ogo N; Matsuno K; Takikawa O; Asai A
Biochem Biophys Res Commun; 2012 Mar; 419(3):556-61. PubMed ID: 22369947
[TBL] [Abstract][Full Text] [Related]
3. S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Matsuno K; Takai K; Isaka Y; Unno Y; Sato M; Takikawa O; Asai A
Bioorg Med Chem Lett; 2010 Sep; 20(17):5126-9. PubMed ID: 20688518
[TBL] [Abstract][Full Text] [Related]
4. Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells.
Ebokaiwe AP; Njoya EM; Sheng Y; Zhang Z; Li S; Zhou Z; Qiang Z; Peng T; Hussein AA; Zhang G; Lu X; Li L; Wang F
Toxicol Appl Pharmacol; 2020 Oct; 404():115203. PubMed ID: 32822738
[TBL] [Abstract][Full Text] [Related]
5. Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human lens epithelial cells: apoptosis through the formation of 3-hydroxykynurenine.
Mailankot M; Nagaraj RH
Int J Biochem Cell Biol; 2010 Sep; 42(9):1446-54. PubMed ID: 20435158
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a polysaccharide from the fruiting bodies of Lepista sordida as potent inhibitors of indoleamine 2, 3-dioxygenase (IDO) in HepG2 cells via blocking of STAT1-mediated JAK-PKC-δ signaling pathways.
Luo Q; Yan L; Xu P; Xiong C; Yang Z; Hu P; Hu H; Hong R
Carbohydr Polym; 2018 Oct; 197():540-547. PubMed ID: 30007645
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl- and monomethylfumarate regulate indoleamine 2,3-dioxygenase (IDO) activity in human immune cells.
Eminel S; Jin N; Rostami M; Dibbert S; Mrowietz U; Suhrkamp I
Exp Dermatol; 2017 Aug; 26(8):685-690. PubMed ID: 27376248
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine production mediated by indoleamine 2,3-dioxygenase aggravates liver injury in HBV-specific CTL-induced fulminant hepatitis.
Ohtaki H; Ito H; Ando K; Ishikawa T; Hoshi M; Ando T; Takamatsu M; Hara A; Moriwaki H; Saito K; Seishima M
Biochim Biophys Acta; 2014 Sep; 1842(9):1464-71. PubMed ID: 24768802
[TBL] [Abstract][Full Text] [Related]
9. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome.
Maria NI; van Helden-Meeuwsen CG; Brkic Z; Paulissen SM; Steenwijk EC; Dalm VA; van Daele PL; Martin van Hagen P; Kroese FG; van Roon JA; Harkin A; Dik WA; Drexhage HA; Lubberts E; Versnel MA
Arthritis Rheumatol; 2016 Jul; 68(7):1688-99. PubMed ID: 26866723
[TBL] [Abstract][Full Text] [Related]
10. Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2, 3-dioxygenase activity in vitro.
Yu CJ; Zheng MF; Kuang CX; Huang WD; Yang Q
J Alzheimers Dis; 2010; 22(1):257-66. PubMed ID: 20847417
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells.
Maghzal GJ; Thomas SR; Hunt NH; Stocker R
J Biol Chem; 2008 May; 283(18):12014-25. PubMed ID: 18299324
[TBL] [Abstract][Full Text] [Related]
12. Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer.
de Jong RA; Nijman HW; Boezen HM; Volmer M; Ten Hoor KA; Krijnen J; van der Zee AG; Hollema H; Kema IP
Int J Gynecol Cancer; 2011 Oct; 21(7):1320-7. PubMed ID: 21720257
[TBL] [Abstract][Full Text] [Related]
13. Sodium butyrate inhibits interferon-gamma induced indoleamine 2,3-dioxygenase expression via STAT1 in nasopharyngeal carcinoma cells.
He YW; Wang HS; Zeng J; Fang X; Chen HY; Du J; Yang XY
Life Sci; 2013 Oct; 93(15):509-15. PubMed ID: 23942267
[TBL] [Abstract][Full Text] [Related]
14. Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells.
Tourino MC; de Oliveira EM; Bellé LP; Knebel FH; Albuquerque RC; Dörr FA; Okada SS; Migliorini S; Soares IS; Campa A
Cell Biochem Funct; 2013 Jul; 31(5):361-4. PubMed ID: 23754498
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
16. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
[TBL] [Abstract][Full Text] [Related]
17. Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels.
Jiang GM; He YW; Fang R; Zhang G; Zeng J; Yi YM; Zhang S; Bu XZ; Cai SH; Du J
Int J Biochem Cell Biol; 2010 Nov; 42(11):1840-6. PubMed ID: 20691806
[TBL] [Abstract][Full Text] [Related]
18. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
Shibata Y; Hara T; Nagano J; Nakamura N; Ohno T; Ninomiya S; Ito H; Tanaka T; Saito K; Seishima M; Shimizu M; Moriwaki H; Tsurumi H
PLoS One; 2016; 11(1):e0146279. PubMed ID: 26727596
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis.
Changsirivathanathamrong D; Wang Y; Rajbhandari D; Maghzal GJ; Mak WM; Woolfe C; Duflou J; Gebski V; dos Remedios CG; Celermajer DS; Stocker R
Crit Care Med; 2011 Dec; 39(12):2678-83. PubMed ID: 21765346
[TBL] [Abstract][Full Text] [Related]
20. Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.
Schefold JC; Zeden JP; Pschowski R; Hammoud B; Fotopoulou C; Hasper D; Fusch G; Von Haehling S; Volk HD; Meisel C; Schütt C; Reinke P
Scand J Infect Dis; 2010 Mar; 42(3):164-71. PubMed ID: 19958238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
